Top compounds associated with response to TP53TG3D


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.006
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.098 0.007
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.099 0.007
mRNA tigecycline CTRPv2 pan-cancer AAC -0.13 0.007
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.087 0.007
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.097 0.007
mRNA TPCA-1 CTRPv2 pan-cancer AAC -0.089 0.007
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.1 0.008
mRNA WZ8040 CTRPv2 pan-cancer AAC -0.11 0.008
Download CSV